Kawasaki disease
blank.png
Title Filter     Display # 
# Article Title
1 Kawasaki disease in adult patients.
2 Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy.
3 Kawasaki disease: clinical spectrum of 88 patients in a high-prevalence African-American population.
4 [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary comp
5 Kawasaki Disease.
6 A randomized prospective study on the use of 2 g-IVIG or 1 g-IVIG as therapy for Kawasaki disease.
7 Fulminant myocarditis successfully treated with high-dose immunoglobulin.
8 Kawasaki disease with severe cardiac sequelae: Lessons from recent New Zealand experience.
9 Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
10 Review and analysis of 283 cases of Kawasaki disease
11 An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of corona
12 Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatmen
13 Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
14 Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatmen
15 An unusual pattern of arthritis in a child with Kawasaki syndrome.
16 Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
17 A national survey on the pediatric cardiologist's clinical approach for patients with Kawasaki disea
18 Update on the treatment of Kawasaki disease in childhood.
19 Labeled WBC cardiac imaging and two-dimensional echocardiography to evaluate high-dose gamma globuli
20 A multicenter, randomized, controlled trial of intravenous gamma globulin therapy in children with a